Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Massachusetts General Hospital Cancer Center
N

ESR1 Mutations and Other Mutational Signatures in HR+/HER2- MBC: Review of the Current Data

By Massachusetts General Hospital Cancer Center FEATURING Nancy Davidson
By Massachusetts General Hospital Cancer Center FEATURING Nancy Davidson
415 views
June 11, 2021
0 Comments
Login to view comments. Click here to Login
Grand Rounds
53:56
Massachusetts General Hospital Cancer Center

Oncologic Anthropology: Genetics of High-Risk/TNBC and African Ances…

Feat. L. Newman
56:23
Massachusetts General Hospital Cancer Center

Environmental Influences on Colorectal Cancer

Feat. J. Carethers
47:34
Massachusetts General Hospital Cancer Center

Confronting Inequity in Modern Therapy for Rare Melanomas

Feat. A. Shoushtari
47:29
Massachusetts General Hospital Cancer Center

Personalizing Care for Older Adults With Cancer

Feat. H. Klepin
50:19
Massachusetts General Hospital Cancer Center

Engineering CAR T-Cells: Combatting Tumor Resistance and Relapse

Feat. R. Brentjens
46:25
Massachusetts General Hospital Cancer Center

Advancing Therapies for Children and Adults With Rare Solid Tumors o…

Feat. B. Widemann
49:26
Massachusetts General Hospital Cancer Center

Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond

Feat. M. Konopleva
12:33
Massachusetts General Hospital Cancer Center

Endocrine Therapy in EBC: Latest Trial Data on Genomic Testing

Feat. N. Davidson
10:26
Massachusetts General Hospital Cancer Center

Radiation Therapy and Localized PDAC: NACRT vs. NAT, Radiation &…

Feat. W. Messersmith, T. Hong
18:49
Massachusetts General Hospital Cancer Center

RT & laPAC: Application in Unresectable Disease, Dose Escalation…

Feat. W. Messersmith, T. Hong
36:51
Massachusetts General Hospital Cancer Center

The Future of Cancer Screening: Non-Standard Screens, Death Rates &a…

Feat. S. Raoof
09:54
Massachusetts General Hospital Cancer Center

Augmenting Response to Endocrine Therapy in BC: The Role of Combinat…

Feat. N. Davidson
15:35
Massachusetts General Hospital Cancer Center

ESR1 Mutations and Other Mutational Signatures in HR+/HER2- MBC: Rev…

Feat. N. Davidson
12:39
Massachusetts General Hospital Cancer Center

Key Adjuvant Studies for Resected Pancreatic Adenocarcinoma: What Da…

Feat. W. Messersmith, T. Hong
12:09
Massachusetts General Hospital Cancer Center

The Role of CDK4/6i in Endocrine Therapy of HR+/HER2- MBC: 1/2L Trea…

Feat. N. Davidson
31:20
Massachusetts General Hospital Cancer Center

Understanding Responses to Cancer Therapy: Lessons Learned From Tran…

Feat. J. Wargo
12:43
Massachusetts General Hospital Cancer Center

What Is the Role of Diet in Response to Cancer Treatment?

Feat. J. Wargo
36:18
Massachusetts General Hospital Cancer Center

Molecular Profiling of Gliomas: Therapeutic Utility of Prognostic &a…

Feat. A. Chakravarti
22:43
Massachusetts General Hospital Cancer Center

The Use of IO in SCLC: Navigating Established IO Mono & Combinat…

Feat. T. Owonikoko
Massachusetts General Hospital Cancer Center

Enhancing the Benefit of IO in SCLC: Considering Emerging Predictive…

Feat. T. Owonikoko
15:48
Massachusetts General Hospital Cancer Center

52 y/o Female With Localized PDAC: How Adequate Is Current Approach?…

Feat. W. Messersmith, T. Hong
48:13
Massachusetts General Hospital Cancer Center

Late Recurrences in ER+ BC: Does Adjuvant ET Decrease the Risk of Re…

Feat. D. Hayes